CTCA @ Midwestern Regional Medical Center

Zion, Illinois 60099

0 studies enrolling now · 3 studies all time

What they study most

Cancer, HER-2 Positive Breast Cancer, Metastatic Neoplasm, NSCLC

Studies at this site

• Phase 2 Study of Poziotinib in Participants With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation — Stopped early
• Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer — Completed
• Study of High-Dose Intravenous (IV) Vitamin C Treatment in Patients With Solid Tumors — Completed